BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal Clinical Infectious Diseases
October 09, 2014 at 16:53 PM EDT
The Medicines Company (NASDAQ: MDCO) today announced the publication of the results from the SOLO II Phase 3 clinical trial of ORBACTIV ...